148 related articles for article (PubMed ID: 7881813)
1. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates exocrine pancreas in conscious preruminating calves.
Zabielski R; Onaga T; Mineo H; Okine E; Kato S
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Sep; 109(1):93-9. PubMed ID: 7881813
[TBL] [Abstract][Full Text] [Related]
2. Dose-response effects of VIP on the rabbit exocrine pancreatic secretion. Comparison with PACAP-27 actions.
Rodríguez-López AM; De Dios I; García LJ; López MA; Calvo JJ
Rev Esp Fisiol; 1995 Mar; 51(1):29-36. PubMed ID: 7569277
[TBL] [Abstract][Full Text] [Related]
3. Comparison between the effects of VIP and the novel peptide PACAP on the exocrine pancreatic secretion of the rat.
Alonso RM; Rodríguez AM; García LJ; López MA; Calvo JJ
Pancreas; 1994 Jan; 9(1):123-8. PubMed ID: 7509062
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats.
Wheeler S; Eardley JE; McNulty KF; Sutcliffe CP; Morrison JD
Exp Physiol; 1997 Jul; 82(4):729-47. PubMed ID: 9257115
[TBL] [Abstract][Full Text] [Related]
5. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on amylase secretion from guinea pig pancreatic acini.
Kitagawa M; Naruse S; Ishiguro H; Hayakawa T; Nokihara K
Biomed Pept Proteins Nucleic Acids; 1995; 1(2):73-6. PubMed ID: 9346857
[TBL] [Abstract][Full Text] [Related]
6. The effect of pituitary adenylate cyclase activating polypeptide (PACAP) on exocrine pancreatic secretion in dogs.
Naruse S; Suzuki T; Ozaki T
Pancreas; 1992; 7(5):543-7. PubMed ID: 1513802
[TBL] [Abstract][Full Text] [Related]
7. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig.
Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB
Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442
[TBL] [Abstract][Full Text] [Related]
8. The effect of VIP/PACAP family of peptides on pancreatic blood flow and secretion in conscious dogs.
Ito O; Naruse S; Kitagawa M; Ishiguro H; Ko S; Nakajima M; Hayakawa T
Regul Pept; 1998 Nov; 78(1-3):105-12. PubMed ID: 9879753
[TBL] [Abstract][Full Text] [Related]
9. Effect of pituitary adenylate cyclase-activating polypeptide on exocrine and endocrine secretion in the ovine pancreas.
Onaga T; Uchida M; Kimura M; Miyazaki M; Mineo H; Kato S; Zabielski R
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1996 Nov; 115(3):185-93. PubMed ID: 9375356
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) on food intake in the goldfish, Carassius auratus.
Matsuda K; Maruyama K; Nakamachi T; Miura T; Uchiyama M; Shioda S
Peptides; 2005 Sep; 26(9):1611-6. PubMed ID: 16112400
[TBL] [Abstract][Full Text] [Related]
11. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
[TBL] [Abstract][Full Text] [Related]
12. Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion.
Mungan Z; Ertan A; Hammer RA; Arimura A
Peptides; 1991; 12(3):559-62. PubMed ID: 1717954
[TBL] [Abstract][Full Text] [Related]
13. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
[TBL] [Abstract][Full Text] [Related]
14. PACAP stimulates pancreatic exocrine secretion via the vagal cholinergic nerves in sheep.
Onaga T; Okamoto K; Harada Y; Mineo H; Kato S
Regul Pept; 1997 Oct; 72(2-3):147-53. PubMed ID: 9652974
[TBL] [Abstract][Full Text] [Related]
15. [Neuroprotective effects of novel derivatives of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide in two brain ischemic models on mice].
Takeda N; Murozono M; Watanabe S; Isshiki A; Watanabe Y
Masui; 2005 Mar; 54(3):240-8. PubMed ID: 15794099
[TBL] [Abstract][Full Text] [Related]
16. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chick hypothalamus and cerebral cortex.
Nowak JZ; Kuba K; Zawilska JB
Pol J Pharmacol; 2000; 52(6):467-71. PubMed ID: 11334241
[TBL] [Abstract][Full Text] [Related]
17. Effect of neural blockades, gastrointestinal regulatory peptides, and diversion of gastroduodenal contents on periodic pancreatic secretion in the preruminant calf.
Zabielski R; Kiela P; Onaga T; Mineo H; Gregory PC; Kato S
Can J Physiol Pharmacol; 1995 Nov; 73(11):1616-24. PubMed ID: 8789416
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat.
Bertrand G; Puech R; Maisonnasse Y; Bockaert J; Loubatières-Mariani MM
Br J Pharmacol; 1996 Feb; 117(4):764-70. PubMed ID: 8646426
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
